December 26, 2016
"What is PRO-140?"
"In what phase of study is injectable cabotegravir?"
"How do latency-reversing agents work?"
AIDSinfo, a service of the U.S. Department of Health and Human Services, has witnessed an increasing interest by users in the investigational portion of the Drug Database. "AIDSinfo drug information is unique in that we provide thorough summaries of not only FDA-approved HIV drugs but also investigational HIV drugs," explained Nicole Scott, AIDSinfo Project Officer, through the Specialized Information Services at the National Library of Medicine. "In response to user feedback, we are expanding the database to house more investigational drugs and will now also include investigational therapeutic HIV vaccines."
Similar to the information provided for other investigational drugs, the therapeutic HIV vaccines have two separate easy-to-read summaries -- one for health consumers and one for researchers and health professionals. Both versions include up-to-date information on relevant clinical trials, possible side effects, and how vaccine research is conducted.
There are currently three investigational therapeutic HIV vaccines in the Drug Database:
In the coming months, additional investigational drugs, including more therapeutic HIV vaccines, will be added to the Drug Database. Users can access the Drug Database at AIDSinfo and infoSIDA or via the AIDSinfo Drug Database App, which can be downloaded to iOS or Android devices. Keep us posted on your experience with the Drug Database. We welcome your questions and comments at ContactUs@aidsinfo.nih.gov.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.